Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

News All News

CBS 2023: Early Bird Registration Deadline Extended 0 comments

by Amanda Clifford
Dear Members, The early bird registration deadline for CBS 2023 in Halifax has been extended to April 21st, 2023 To register, click here...
more

CBS 2023: Abstract Submission Extended 0 comments

by Amanda Clifford
Dear Members, The abstract submission deadline for CBS 2023 in Halifax has been extended to March 17th, 2023 Please click here to learn more...
more

Call for Paper and Special Issues Open access and Free of Charge The Exploration of Biomat-X Journal 0 comments

by Amanda Clifford
The Exploration of Biomat-X EBMX invites you to submit your next original contribution to the inaugural edition of this journal to help the journal positioning itself among the major players in the field...
more

CBS 2023: Registration is Open! 0 comments

by Amanda Clifford
Dear Members, Reistration for CBS 2023 at Dalhousie University in Halifax, NS is officially open You can register here...
more

Meetings All Meetings

Discover

Development of self-associating SN-38-conjugated poly(ethylene oxide)-poly(ester) micelles for colorectal cancer therapy comments

by Afsaneh Lavasanifar Sams Sadat
The clinical use of 7-ethyl-10-hydroxy-camptothecin SN-38 , the active metabolite of irinotecan, has been hampered because of its practical water-insolubility...
more

Examining The Proinflammatory and Profibrotic Effects of Adsorbed Damage-Associated-Molecular-Patterns and Toll-Like Receptor 2-Dependent Signaling in Macrophages comments

by Lindsay Fitzpatrick Anuj Kaushal
The foreign body reaction is an aberrant wound healing process that occurs in response to an implanted biomaterial, which can lead to it failing prematurely...
more

Fabrication and Characterization of Shear Thinning Biomaterial for Intra-tumoral Delivery of Doxorubicin comments

by Sadaf Samimi Gharaie
Doxorubicin is widespread and influential apoptosis-inducing drug in cancer chemotherapy which interdicts DNA replication and treats different types of cancers including, benign, potentially-malignant, glioblastoma malignant tumours 1 2 3 ...
more

Sulfur-rich hydrogel surfaces for biocompatibility enhancement and biomolecule immobilization comments

by Pierre-Luc Girard-Lauriault Bishakh Rout
Hydrogels are good candidates for use as biomaterials, with general characteristics that make them amenable to the internal biological environment...
more

Visible Light Responsive Hydrogel for Affinity-Controlled Long-Term Release of Glial Cell Line-Derived Neurotrophic Factor (GDNF) comments

by Brian Amsden Ronghui Qi
Optic neuropathy is a common cause of vision loss resulting from death of retinal ganglion cells due to insufficient blood flow, inflammation, infection or trauma...
more

Connect

Active Job Postings

  • Postdoctoral Researcher in Conductive Polymer–Based Supercapacitors
    more
  • TIER 2 CANADA RESEARCH CHAIR IN CELL ENGINEERING AND BIOMANUFACTURING
    more
  • Assistant, Associate, or Full Professor in Bioprocessing and Biomanufacturing
    more
  • Research Associate in Next-Generation RNA Therapeutics at UBC
    more

Recent Member Projects

  • Ze Zhang: Biomaterials in biomedical engineering
    more
  • Vanessa Xu: A Modular Microfluidic Device for Tandem Vascular-Extravascular Network Integration
    more
  • Alaa Al-Shaer: Enabling Clinically Viable Engineered Tissues with a Bioactive, Animal-Free Biomaterial
    more
  • Doris Liang: Mineralization in fractured femurs
    more

Recent Member Publications

  • Robyn Birch: Denosumab treatment of giant cell tumors in the spine induces woven bone formation
    more
  • Daniel Nguyen: Mechanically Stable and Tunable Photoactivated Peptide-Based Hydrogels for Soft Tissue Adhesion
    more
  • German Andres Mercado: Mechanically Stable and Tunable Photoactivated Peptide-Based Hydrogels for Soft Tissue Adhesion
    more
  • German Andres Mercado: Multipurpose On-the-Spot Peptide-Based Hydrogels for Skin, Cornea and Heart Repair
    more
Close Drag